Innovative Research Award
| Yichao Xu |
| Affiliation |
Zhejiang University |
| Country |
China |
| Scopus ID |
57195473151 |
| Documents |
30 |
| Citations |
220 |
| h-index |
8 |
| Subject Area |
Pharmacology and Drug Development |
| Event |
World Life Science Awards |
Yichao Xu is a researcher affiliated with Zhejiang University in China whose supplied academic profile is associated with pharmacology and drug development. The provided profile lists Scopus Author ID 57195473151 and records 30 documents, 220 citations, and an h-index of 8. These bibliometric indicators offer a quantitative overview of the research activity represented in the supplied Scopus profile. [1]
Abstract
This academic recognition profile presents the supplied research information for Yichao Xu, a researcher affiliated with Zhejiang University, China, and associated with pharmacology and drug development. The provided Scopus profile identifies the researcher through Author ID 57195473151 and lists 30 indexed documents, 220 citations, and an h-index of 8.These bibliometric indicators summarize aspects of indexed scholarly output and citation visibility. [1]
Keywords
- Yichao Xu
- Pharmacology
- Drug development
- Zhejiang University
- Research innovation
- Pharmaceutical research
- Drug discovery
- Scientific research
- Bibliometric indicators
- Scopus
- Innovative Research Award
- World Life Science Awards
Introduction
Pharmacology examines how substances interact with biological systems, including the mechanisms through which drugs produce their effects. Drug development applies scientific evidence and experimental methods to the discovery, evaluation, and development of potential therapeutic products.[2]
Research Profile
The supplied information identifies Yichao Xu as being affiliated with Zhejiang University in China and associates the research profile with pharmacology and drug development.No specific laboratory, research group, individual research project, or detailed experimental specialization was included in the supplied information. Accordingly, this profile does not attribute particular drug candidates, therapeutic discoveries, clinical outcomes, or research methods to the researcher without supporting evidence.
Research Contributions
Pharmacology and drug development encompass research questions related to drug action, biological targets, therapeutic efficacy, safety, and the evaluation of candidate compounds. Work in these fields may contribute to understanding disease mechanisms, identifying potential therapeutic approaches, and establishing evidence to guide further investigation. [2]
Publications
The supplied profile reports 30 documents under Scopus Author ID 57195473151. [Individual publication titles, publication dates, journal names, co-authors, abstracts, and DOI identifiers were not provided as source information for this article. Therefore, no specific publication is attributed to Yichao Xu here without bibliographic verification.The available records should be reviewed directly to confirm publication details and their relevance to pharmacology and drug development.
Research Impact
The supplied Scopus profile reports 220 citations across 30 documents and an h-index of 8. [1] Citation counts provide one measure of how often indexed publications are cited by other scholarly works. The h-index combines publication output and citation activity by identifying a threshold of publications that have each received at least that number of citations. [3]
Award Suitability
This profile is presented in connection with the Innovative Research Award at the World Life Science Awards. The supplied institutional affiliation, subject-area association, and bibliometric indicators provide background information for considering the research profile within an academic recognition context. [1]
A comprehensive award assessment would require review of the candidate’s verified publications, originality of research, methodological quality, documented contributions to pharmacology or drug development, and supporting evidence of research impact. The information presented here does not by itself establish award selection, final eligibility, or an official award outcome.
Conclusion
Yichao Xu is identified in the supplied academic information as a researcher affiliated with Zhejiang University in China and associated with pharmacology and drug development. The provided Scopus profile lists 30 documents, 220 citations, an h-index of 8, and Author ID 57195473151. These figures offer a concise bibliometric overview, while further assessment of individual research contributions requires examination of verified publications and supporting evidence. [1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Yichao Xu, Author ID 57195473151. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57195473151
- Direct background subtraction LC-MS/MS assay for human plasma progesterone: Full validation and comparative application. Journal of Chromatography B, 1282, 125221.
https://doi.org/10.1016/j.jchromb.2026.125221
- Physiologically based pharmacokinetic model of brigatinib in healthy volunteers and patients with cancer. CPT: Pharmacometrics & Systems Pharmacology, 15(8), e70302.
https://doi.org/10.1002/psp4.70302